Back to Research Hub
Liquidia Corporation
LQDA
$67.19-0.50 (-0.73%)
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States.
StreetsValue research for Liquidia Corporation (LQDA)
Members get the full report for Liquidia Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.